Publication | Closed Access

Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model

VaccinationCross-protectionVaccine DevelopmentVaccine TargetImmunologyAluminum AdjuvantVirologyInfluenza VaccineVaccine DesignMedicineMouse ModelLethal ChallengeInfluenza Vaccines